A detailed history of Kula Investments, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 8,557 shares of MRNA stock, worth $327,305. This represents 0.32% of its overall portfolio holdings.

Number of Shares
8,557
Previous 4,873 75.6%
Holding current value
$327,305
Previous $875 Million 50.14%
% of portfolio
0.32%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $499,771 - $725,821
3,684 Added 75.6%
8,557 $1.31 Billion
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $576,865 - $1.02 Million
4,873 New
4,873 $875 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.